original ) (raw )Oxidized low-density-lipoprotein accumulation is associated with liver fibrosis in experimental cholestasis
Ishak Tekin
Clinics, 2008
View PDFchevron_right
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease
Zobair Younossi
Human Pathology, 2004
View PDFchevron_right
Cholesterol and Inflammation at the Crossroads of Non-Alcoholic Fatty Liver Disease (NAFLD) and Atherogenesis
Damjana Rozman
Atherogenesis, 2012
View PDFchevron_right
Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries
Eduardo Schiffer
Laboratory Investigation, 2007
View PDFchevron_right
Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease
Shu-li Ho
Journal of Inflammation, 2019
View PDFchevron_right
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
Luc Van Gaal
Nature Communications, 2014
View PDFchevron_right
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network
Mark Pabst
Hepatology, 2008
View PDFchevron_right
The Association of Nicotinamide Phosphoribosyltransferase Polymorphism with Markers of Hepatic Injury and De Novo Lipogenesis in Nonalcoholic Fatty Liver Disease
Parvaneh Rahimi-Moghaddam
Hepatitis Monthly
View PDFchevron_right
Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease
Alastair Burt
Laboratory Investigation, 2008
View PDFchevron_right
573 The ballooned hepatocyte in NAFLD: Degenerative or adaptive?
LISA KRUGNER-HIGBY
Journal of Hepatology, 2004
View PDFchevron_right
Nonalcoholic fatty liver disease (NAFLD)--two decades later: are we smarter about its natural history?
Janus Ong‡
The American journal of gastroenterology, 2003
View PDFchevron_right
Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
Saleh Daher
PLOS ONE, 2018
View PDFchevron_right
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
Silvana Zanlungo
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015
View PDFchevron_right
CHOLESTATIC LIVER FIBROSIS IN A RAT MODEL OF BILE DUCT LIGATION: EVALUATING BIOCHEMICAL VERSUS HISTOPATHOLOGICAL CHANGES
International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS)
International Journal of Pharmacy and Pharmaceutical Sciences, 2015
View PDFchevron_right
Cholesterol and nonalcoholic fatty liver disease: Renewed focus on an old villain
Nicholas Davidson
Hepatology, 2012
View PDFchevron_right
Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
phunchai charatcharoenwitthaya
Gastroenterology, 2015
View PDFchevron_right
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Giulio Marchesini
Hepatology, 2007
View PDFchevron_right
1268 Differential Expression of Hepatic Fas and Its Ligand Faslg Expression in Non-Alcoholic Fatty Liver Disease (Nafld)
Amanda Zirzow
Journal of Hepatology, 2012
View PDFchevron_right
Liver fibrosis: from mechanisms to treatment
Scott Friedman
Gastroentérologie Clinique et Biologique, 2007
View PDFchevron_right
Association of Serum Cytokines with Liver Fibrosis as Measured by Computerized Morphometry across Diseases of NAFLD Spectrum
Sasha Stoddard
2017
View PDFchevron_right
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
Luca Valenti
Current Pharmaceutical Design, 2013
View PDFchevron_right
Non-Alcoholic Fatty Liver Disease: Pathogenesis and the Significance of High-Density Lipoprotein as a Molecular Modifier
IBRAHIM KWAIFA
IntechOpen eBooks, 2023
View PDFchevron_right
Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
Jafor Sadeque
Cureus, 2021
View PDFchevron_right
Molecular pathways in non-alcoholic fatty liver disease
Esther Guiu-Jurado , Alba Berlanga , Teresa Auguet
Clinical and Experimental Gastroenterology, 2014
View PDFchevron_right
Risk of severe liver disease in nonalcoholic fatty liver disease: Role of insulin resistance
Luca Valenti
Hepatology, 2008
View PDFchevron_right
G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients
David Pacheco
Annals of hepatology
View PDFchevron_right
Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD
Giovanni Targher
Current Pharmaceutical Design, 2013
View PDFchevron_right
Alterations in Lipid Metabolism Mediate Inflammation, Fibrosis, and Proliferation in a Mouse Model of Chronic Cholestatic Liver Injury
Peter Fickert
Gastroenterology, 2012
View PDFchevron_right
The riddle of Nonalcoholic fatty liver disease: Progression from NAFL to NASH
Rathindra Mukherjee
Journal of Clinical and Experimental Hepatology, 2015
View PDFchevron_right
NAFLD fibrosis score: A prognostic predictor for mortality and liver complications among NAFLD patients
S. Suwanwalaikorn
World Journal of Gastroenterology, 2013
View PDFchevron_right
Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity
Gustavo Castaño
Hepatology, 2015
View PDFchevron_right
Reply to: “Non-invasive prediction of fibrosis in nonalcoholic fatty liver disease”
Eduardo Fassio
Journal of Hepatology, 2011
View PDFchevron_right
Validity of routine biochemical and ultrasound scores for prediction of hepatic fibrosis and steatosis in NAFLD
Yasmin Saad
Egyptian Liver Journal
View PDFchevron_right
Epicardial Fat in patients with nonalcoholic fatty liver disease
Antonio Craxì
Journal of Hepatology, 2015
View PDFchevron_right
The Kruppel-Like Factor 6 Genotype Is Associated With Fibrosis in Nonalcoholic Fatty Liver Disease
Scott Friedman
Gastroenterology, 2008
View PDFchevron_right